期刊文献+

动脉介入法向猪胰腺注射Fe_3O_4磁流体

The Study of Fe_3O_4 Magnetic Fluid Inject into the Pancreas of Porcine Following Arterial Intervention
下载PDF
导出
摘要 目的探讨通过动脉介入方式向猪的胰腺注射Fe3O4磁流体的可行性。方法采用seldinger法,经股动脉将SP管插到脾动脉,向胰腺供血动脉注射浓度为100mg/ml的Fe3O4磁流体1ml。磁流体注射6天后处死实验动物,取其胰腺及其他内脏器官,行组织切片HE染色。结果通过动脉介入的方式成功向胰腺内注射磁流体,经病理检查显示磁流体分布于注射部位胰腺内,其他脏器未见明显的磁流体分布。结论通过动脉介入方式向胰腺内注射磁流体是可行的,并没有引起胰腺组织的明显损伤。 Objective To discuss the feasibility of injecting Fe3O4 magnetic fluid into the pancreas of porcine which used in hyperthermia following transcatheter arterial intervention. Methods The spleen artery was reached with a SP catheter via a femoral route by seldinger technique ,then inject lml of Fe3O4 magnetic fluid ( 100 mg/ml) to pancreas from artery 6 days after the injection of magnetic fluid, animals were sacrificed, pancreas and other organs were taken and fixed in 10% formaldehyde, embedded in paraffin,cut into thin sections and stained by hematoxylin-eosin( H&E staining). Results Magnetic fluid was successfully injected into the pancreas by transcatheter arterial intervention. Histological examination shows that magnetic fluid distributed equably in the pancreas. There was no magnetic fluid distribution in other organs. Conclusion It is feasible to inject magnetic fluid into pancreas following transcatheter arterial intervention, and there is no obvious scathe in pancreas tissue.
出处 《实用癌症杂志》 2010年第2期111-113,132,共4页 The Practical Journal of Cancer
基金 云南省科技厅国际科技合作暨科技兴贸专项计划(2006GH20)
关键词 磁流体 胰腺 介入 Magnetic fluid Porcine Pancreas Arterial intervention
  • 相关文献

参考文献13

  • 1Rosenberg L, Lipsettm. Biotherapeutic approaches to pancreatic cancer[J].Expert Opin Biol Ther,2003,3 (2) :319.
  • 2郭春光,赵平.胰腺癌分子靶向治疗进展[J].癌症进展,2008,6(1):24-29. 被引量:5
  • 3Jordan A, Scholz R, Wust P, et al. Magnetic fluid hyperthermia (MFH) : cancertreatment with AC magnetic field induced excitation of biocompatible superpara magnetic nano- particles[J]. J Magn Magn Mater, 1999,201 ( 1-3 ) :413.
  • 4T Onur Tasci, Ibrahim Vargel, Anil Arat, et al. Focused RF hyperthermia using magnetic fluids [J]. Med Phys ,2009 ,36 (5) :1905.
  • 5蒋秉植,杨健美.磁性液体材料的应用[J].化工新型材料,1994,22(4):1-5. 被引量:17
  • 6Jordan A, Wust P, Scholz R, et al. Effects of magnetic fluid hyperthermia(MFH) on C3H mammary carcinoma in vivo [J]. Int J Hyperthermia, 1997,13 (6) :587.
  • 7Jordan A, Wust P, Scholz R, et al. Cellular uptake of magnetic fluid particles and their effects on human adenoearei- noma cells exposed to AC magnetic fields in vitro[J]. Int J Hyperthermia, 1996,12 ( 6 ) : 705.
  • 8Andreas Jordan, Regina Scholz, Klaus Maier-Hauff, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma[J].Journal of Neuro-Oncology,2006, 78:7.
  • 9Paul Moroz, Stephen K Jones, Jillean Winter, et al. Targeting liver tumors with hyperthermia:ferromagnetic embolization in a rabbit liver tumor model [J]. Journal of Surgical Oncology,2001,78 :22.
  • 10Akira Ito, Fumiko Matsuoka, Hiroyuki Honda, et al. Antitnmor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma[J].Cancer Immunol Immunother,2004,53:26.

二级参考文献31

  • 1[1]D.Max Parkin,Freddie Bray,J.Ferlay,et al.Global Cancer Statistics,2002.CA Cancer J Clin,2005,55:74
  • 2[2]Kindler H.L.Front-line therapy of advanced pancreatic cancer.Semin Oncol,2005,32:S33
  • 3[3]Abrams R.A.Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.Semin Oncol,2005,32:S30
  • 4[4]Seo Y,Baba H,Fukuda T,et al.High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.Cancer,2000,88 (10):2239
  • 5[5]Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer.N Engl J Med,2004,350(23):2335
  • 6[6]Kindler Hedy L,Friberg Gregory,Singh Deepti A,et al.Phase Ⅱ trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.J Clin Oncol,2005,23(31):8033
  • 7[7]Gordon J.N,Goggin P.M.Thalidomide and its derivatives:Emerging from the wilderness.Postgrad Med J,2003,79 (929):127
  • 8[8]Eleutherakis-Papaiakovou V,Bamias A,Dimopoulos M.A.Thalidomide in cancer medicine.Ann Oncol,2004,15 (8):1151
  • 9[9]Maples W.J,Stevenson J,Sumrall S.V,et al.Advanced pancreatic cancer:A multi-institutional trial with gemcitabine and thalidomide.J Clin Oncol,2004,22(14S):4082
  • 10[10]Gordon J.N,Trebble T.M,Ellis R.D,et al.Thalidomide in the treatment of cancer cachexia:A randomised placebo controlled trial.Gut,2005,54 (4):540

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部